Ryota Horibe

Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition

Yosuke Shionoya, Takayuki Kanaseki, Sho Miyamoto et al. · OncoImmunology · 2017 · 66 citations · Full text

Life Sciences, Immunology, Oncology +17

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy

Takuya Asano, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Oncotarget · 2016 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +15

Plasticity of lung cancer stem-like cells is regulated by the transcription factor <i>HOXA5</i> that is induced by oxidative stress

Hiroshi Saijo, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Oncotarget · 2016 · 40 citations · Full text

Medicine, Cell Biology, Oncology +14

Non‐bacterial cystitis with increased expression of programmed death‐ligand 1 in the urothelium: An unusual immune‐related adverse event during treatment with pembrolizumab for lung adenocarcinoma

Yohei Ueki, Masahiro Matsuki, Terufumi Kubo et al. · IJU Case Reports · 2020 · 29 citations · Full text

Medicine, Immunology, Pathology +17

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy

Ryota Horibe, Yoshihiko Hirohashi, Takuya Asano et al. · PLoS ONE · 2017 · 20 citations · Full text

Life Sciences, Immunology, Oncology +17